Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gropep Bioreagents

Gropep Bioreagents
1988 FOUNDED
M&A STATUS
71-80 EMPLOYEES
M&A LATEST DEAL TYPE
2 FINANCING ROUNDS
Description

Developer of biologically active proteins designed for culture and biomedical research. The company's biologically active proteins for cell are used in the production of biological therapeutics such as monoclonal antibodies, recombine proteins and vaccines enabling clients to develop bio pharmaceuticals from pre-clinical trials.

Website
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • PO Box 10065 BC
  • Adelaide, South Australia 5000
  • Australia

+61 (08) 0000 0000

Gropep Bioreagents Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Gropep Bioreagents‘s full profile, request access.

Request full access to PitchBook

Gropep Bioreagents Executive Team (3)

Name Title Board
Seat
Contact
Info
Robert Finder Managing Director & Chief Executive Officer
Anthony Mitchell Chief Financial Officer
Chris Goddard Managing Director